CELL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2024-06-29 1defa333m71(暂无匿称) 来自重庆

cell 投稿后With editor到底多久呀？官网8天，但时间远超了

123 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2021-01-14 张晓梅-Xiaomei Zhang

别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。
如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值

523 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2022-09-05 monkeyjun

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：基因组学
经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。

498 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2022-10-08 12415e1cm11暂无昵称

同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有

405 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2022-08-29 632005764

偏重的研究方向：单细胞测序
经验分享：爱过。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2014-03-07 ninth9

审稿速度:1.0 | 投稿命中率:5.0
经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT.

1291 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2019-02-06 hengyuanxiang

请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢

957 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2021-12-28 乌云背后的幸福线

题目中是否需要对专有名词进行缩写？

668 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2021-12-27 Mia

审稿人一般更青睐于什么样的题目？

721 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2212367, encodeId=9899221236e37, content=cell 投稿后With editor到底多久呀？官网8天，但时间远超了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=123, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22c91735717, createdName=1defa333m71(暂无匿称), createdTime=Sat Jun 29 19:01:23 CST 2024, time=2024-06-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=916629, encodeId=6bfa91662913, content=别看大牛在上面灌水，可是文章的创新确实不一般，不是简单的堆数据量就能上的。 如果文章被cell拒搞也不要灰心，能给审稿意见就是大赚，能审cell的审稿人眼界确实不一般，给的意见也非常的有价值, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=523, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Thu Jan 14 20:49:55 CST 2021, time=2021-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1243266, encodeId=9fc01243266b3, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：基因组学 经验分享：已经投了两周，还在with editor.....不知道多久才拒。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=498, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3b122087799, createdName=monkeyjun, createdTime=Mon Sep 05 09:46:54 CST 2022, time=2022-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2092480, encodeId=1bd3209248052, content=同学作为通讯作者发了一篇，我是来看看这期刊怎么样，毕竟同学很水，五年了一篇sci都没有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=405, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/VYGsX13Ziac1ZicnRHKDxIianZRIoHwY6h9ibH623ibMvvqU3YkxGC4QbV5KXFSfjSSuFauDVS7g2xianPbHmOmqTicvg/132, createdBy=87482459924, createdName=12415e1cm11暂无昵称, createdTime=Sat Oct 08 13:13:06 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241904, encodeId=5356124190452, content=偏重的研究方向：单细胞测序 经验分享：爱过。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47db2969642, createdName=632005764, createdTime=Mon Aug 29 20:26:45 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501627, encodeId=d11b50162e19, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：发这个杂志是中国人的梦想，对创新要求很高，审稿回复很快，可发摘要询问，合适再投。如果稍差点可投到CELL REPORT., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1291, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88df8818, createdName=ninth9, createdTime=Fri Mar 07 19:21:00 CST 2014, time=2014-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566513, encodeId=957b566513a3, content=请问大家，对Cell杂志的文章，想做comment或者letter，怎么投稿呢？杂志选项中没有这项。谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=957, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=effb83900, createdName=hengyuanxiang, createdTime=Wed Feb 06 14:45:00 CST 2019, time=2019-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088468, encodeId=d41610884684e, content=题目中是否需要对专有名词进行缩写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=668, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1088467, encodeId=e70a108846eef, content=审稿人一般更青睐于什么样的题目？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=721, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067762, encodeId=3f10106e762fe, content=针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=769, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3862114504, createdName=第六号染色体, createdTime=Sun Nov 07 11:16:26 CST 2021, time=2021-11-07, status=1, ipAttribution=)]

2021-11-07 第六号染色体

针对Cell上面的论文，我写了篇comment，经过1一个半月评审，编辑同意发布，不知道后续怎么操作啊？

769 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务